Role of SGLT2 inhibitors in cancer therapy-related cardiac dysfunction (CTRCD) in adults: systematic review and meta-analysis: SGLT2 inhibitors and CTRCD

Gustavo Adolfo Vásquez-Tirado; Edinson Dante Meregildo-Rodríguez; Claudia Vanessa Quispe-Castañeda; Wilson Marcial Guzmán-Aguilar; Leslie Jacqueline Liñán-Díaz; Percy Hernán Abanto-Montalván; Víctor Serna-Alarcón; Hugo Alva-Guarniz; Mariano Ortiz-Pizarro; Luis Ángel Rodríguez-Chávez; María Cuadra-Campos

doi:10.1007/s00210-025-04489-x

Role of SGLT2 inhibitors in cancer therapy-related cardiac dysfunction (CTRCD) in adults: systematic review and meta-analysis: SGLT2 inhibitors and CTRCD

Gustavo Adolfo Vásquez-Tirado
, Edinson Dante Meregildo-Rodríguez
, Claudia Vanessa Quispe-Castañeda
, Wilson Marcial Guzmán-Aguilar
, Leslie Jacqueline Liñán-Díaz
, Percy Hernán Abanto-Montalván
, Víctor Serna-Alarcón
, Hugo Alva-Guarniz
, Mariano Ortiz-Pizarro
, Luis Ángel Rodríguez-Chávez
, María Cuadra-Campos

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

Idioma original	Inglés
Publicación	Naunyn-Schmiedeberg's Archives of Pharmacology
DOI	https://doi.org/10.1007/s00210-025-04489-x
Estado	Aceptada/en prensa - 1 ene. 2025
Publicado de forma externa	Sí

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Acceder al documento

10.1007/s00210-025-04489-x

Otros archivos y enlaces

Enlace a la publicación en Scopus

Citar esto

Vásquez-Tirado, G. A., Meregildo-Rodríguez, E. D., Quispe-Castañeda, C. V., Guzmán-Aguilar, W. M., Liñán-Díaz, L. J., Abanto-Montalván, P. H., Serna-Alarcón, V., Alva-Guarniz, H., Ortiz-Pizarro, M., Rodríguez-Chávez, L. Á., & Cuadra-Campos, M. (Aceptado/En prensa). Role of SGLT2 inhibitors in cancer therapy-related cardiac dysfunction (CTRCD) in adults: systematic review and meta-analysis: SGLT2 inhibitors and CTRCD. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04489-x

@article{8b1e1fe8701944c8817db0c4a715063d,

title = "Role of SGLT2 inhibitors in cancer therapy-related cardiac dysfunction (CTRCD) in adults: systematic review and meta-analysis: SGLT2 inhibitors and CTRCD",

keywords = "Cancer therapy-related cardiac dysfunction, Cardiotoxicity, Meta-analysis, Mortality, SGLT2 inhibitors, Systematic review",

author = "V{\'a}squez-Tirado, \{Gustavo Adolfo\} and Meregildo-Rodr{\'i}guez, \{Edinson Dante\} and Quispe-Casta{\~n}eda, \{Claudia Vanessa\} and Guzm{\'a}n-Aguilar, \{Wilson Marcial\} and Li{\~n}{\'a}n-D{\'i}az, \{Leslie Jacqueline\} and Abanto-Montalv{\'a}n, \{Percy Hern{\'a}n\} and V{\'i}ctor Serna-Alarc{\'o}n and Hugo Alva-Guarniz and Mariano Ortiz-Pizarro and Rodr{\'i}guez-Ch{\'a}vez, \{Luis {\'A}ngel\} and Mar{\'i}a Cuadra-Campos",

note = "Publisher Copyright: {\textcopyright} The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2025.",

year = "2025",

month = jan,

day = "1",

doi = "10.1007/s00210-025-04489-x",

language = "English",

journal = "Naunyn-Schmiedeberg's Archives of Pharmacology",

issn = "0028-1298",

publisher = "Springer Science and Business Media Deutschland GmbH",

}

Vásquez-Tirado, GA, Meregildo-Rodríguez, ED, Quispe-Castañeda, CV, Guzmán-Aguilar, WM, Liñán-Díaz, LJ, Abanto-Montalván, PH, Serna-Alarcón, V, Alva-Guarniz, H, Ortiz-Pizarro, M, Rodríguez-Chávez, LÁ & Cuadra-Campos, M 2025, 'Role of SGLT2 inhibitors in cancer therapy-related cardiac dysfunction (CTRCD) in adults: systematic review and meta-analysis: SGLT2 inhibitors and CTRCD', Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04489-x

Role of SGLT2 inhibitors in cancer therapy-related cardiac dysfunction (CTRCD) in adults: systematic review and meta-analysis: SGLT2 inhibitors and CTRCD. / Vásquez-Tirado, Gustavo Adolfo; Meregildo-Rodríguez, Edinson Dante; Quispe-Castañeda, Claudia Vanessa et al.
En: Naunyn-Schmiedeberg's Archives of Pharmacology, 01.01.2025.

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

TY - JOUR

T1 - Role of SGLT2 inhibitors in cancer therapy-related cardiac dysfunction (CTRCD) in adults

T2 - systematic review and meta-analysis: SGLT2 inhibitors and CTRCD

AU - Vásquez-Tirado, Gustavo Adolfo

AU - Meregildo-Rodríguez, Edinson Dante

AU - Quispe-Castañeda, Claudia Vanessa

AU - Guzmán-Aguilar, Wilson Marcial

AU - Liñán-Díaz, Leslie Jacqueline

AU - Abanto-Montalván, Percy Hernán

AU - Serna-Alarcón, Víctor

AU - Alva-Guarniz, Hugo

AU - Ortiz-Pizarro, Mariano

AU - Rodríguez-Chávez, Luis Ángel

AU - Cuadra-Campos, María

N1 - Publisher Copyright: © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2025.

PY - 2025/1/1

Y1 - 2025/1/1

KW - Cancer therapy-related cardiac dysfunction

KW - Cardiotoxicity

KW - Meta-analysis

KW - Mortality

KW - SGLT2 inhibitors

KW - Systematic review

UR - https://www.scopus.com/pages/publications/105012378850

U2 - 10.1007/s00210-025-04489-x

DO - 10.1007/s00210-025-04489-x

M3 - Article

AN - SCOPUS:105012378850

SN - 0028-1298

JO - Naunyn-Schmiedeberg's Archives of Pharmacology

JF - Naunyn-Schmiedeberg's Archives of Pharmacology

ER -

Vásquez-Tirado GA, Meregildo-Rodríguez ED, Quispe-Castañeda CV, Guzmán-Aguilar WM, Liñán-Díaz LJ, Abanto-Montalván PH et al. Role of SGLT2 inhibitors in cancer therapy-related cardiac dysfunction (CTRCD) in adults: systematic review and meta-analysis: SGLT2 inhibitors and CTRCD. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025 Ene. 1. doi: 10.1007/s00210-025-04489-x

Role of SGLT2 inhibitors in cancer therapy-related cardiac dysfunction (CTRCD) in adults: systematic review and meta-analysis: SGLT2 inhibitors and CTRCD

ODS de las Naciones Unidas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto